Medi vs CollaborateMD

Short answer

CollaborateMD is one of the few real head-to-head options for a billing company, not a practice-management tool that bolted on a billing page. It has sold to billing services since 1999, runs genuine multi-client infrastructure, and sits inside the EverHealth family (EverCommerce, NASDAQ: EVCM) after its 2019 acquisition. Medi is newer, billing-company-first from the ground up, and built deepest at the denial and ERA review layer.

The split is clean. **Choose CollaborateMD** for a long track record, a large reference base, and twenty-plus EHR integrations. **Choose Medi** for published per-practice pricing ($20 per client practice, no per-provider fee, volume pricing available) and a workflow built around what a poster or denial lead does daily. The sharpest structural difference: Medi publishes its base rate and full per-transaction schedule, with volume pricing available; CollaborateMD does not publish pricing on its own site, but a BestNotes partner price sheet lists about $0.38 per claim (declining with volume) and about $54 per provider, and a $235/month account-level minimum is cited in partner materials; billing-company subscription tiers are gated and come by private quote.

Choose Medi if billing is your whole business

Medi is built for billing companies that run revenue cycle as their core product, not as a service attached to practice management. The platform fee is $20 per client practice per month, with volume pricing available. Adding providers inside a practice never changes the fee. EDI usage runs on top.

Medi has no scheduling, charting, EHR, or patient engagement modules. The buyer is the billing company, and every screen, queue, and permission model reflects that. Medi tends to fit when:

• Your clients already run an EHR and you want to own the billing layer independently.
• Your team works by function — posters work all clients' ERAs, denial leads work all clients' denials — rather than by client assignment.
• You want claim-level and ERA-line-level audit logs retained seven years (HIPAA Security Rule §164.312(b)) without negotiating a retention package.
• You are leaving a per-provider system and want switching costs that are fixed and published, not a per-provider fee that compounds as the book grows.
• You want EDI without a separate clearinghouse contract — Medi runs on Stedi for 837 submission, 835 ERA, 270/271 eligibility, 276/277 claim status, and 278 authorization.

Choose CollaborateMD if track record and ecosystem breadth matter

CollaborateMD has sold to billing companies long enough to have real institutional knowledge of the workflow. Its medical-billing language — "manage high claim volumes across multiple clients" — reflects genuine investment in the use case. That matters when you need reference customers, proven implementations, or a vendor that has weathered the Change Healthcare outage, payer-portal churn, and the ICD-10 transition.

It also integrates with more than two dozen EHRs via HL7, ships an AI-assisted Universal Import for charge data, and shares infrastructure with EverHealth's communication and patient-engagement tools. CollaborateMD tends to fit when:

• You want a long reference-customer list and documented implementations in your specialty mix.
• Your clients expect tight EHR integration and you want that to be the vendor's problem.
• Your practice-management needs are heavier — scheduling, patient intake, broadcast messaging — alongside the billing work.
• You want a product ecosystem that grows with your clients' clinical operations.

Pricing model

Medi's full schedule is below. CollaborateMD does not publish pricing on its own site; a BestNotes partner price sheet lists about $0.38 per claim (declining with volume to about $0.19 at high volume) and about $54 per provider, with a $235/month account-level minimum also cited in partner materials; billing-company subscription tiers are gated and come by private quote. The numbers in the right column are from partner and reviewer sources as noted.

CollaborateMD's per-provider structure grows with each provider added to the book; the exact number depends on claim volume per provider and tier, which is why a direct quote is worth getting.

The bigger question is what each model does as the book scales. Per-provider pricing creates a direct cost line per provider that some owners prefer for client billing. Per-practice pricing means adding providers inside an existing client never raises the software cost, and the rate steps down at each band threshold. Neither is objectively better — it depends on how your client contracts are structured. But only one is fully published before you talk to sales.

Multi-practice workflow comparison

Both platforms run multi-client operations from a single login. The real question is what the work feels like at the operator level.

CollaborateMD offers a centralized dashboard with role-based access, single sign-on across client accounts, and portfolio-wide reporting — biller productivity, denial trends by client or payer, days-in-A/R across the book. Its Universal Import uses AI-assisted column mapping for charge data from EHR exports. The model is account-oriented: one account manager owns one or more client practices and works within that client's context.

Medi treats the billing company as the workspace and each practice as a scoped tenant inside it. A denial lead sees every client's open denials in one queue with no account-switching. A poster works every client's ERA exceptions from one screen. Practice-level permissions let an offshore poster access four of ten clients without seeing the other six. All-practices views aggregate aging, claim status, and recovery flags across the book without exiting a client context.

Worth testing in a side-by-side of either platform:

• Where does cross-client denial work live, and can a specialist work eight clients' queues without switching accounts?
• How do per-client billing rules (write-off thresholds, hold policies, ERA acceptance) stack on top of payer rules?
• What does the all-book A/R aging view look like, and how fast is a practice-level drill-in?
• How do you restrict an offshore poster to a subset of clients without separate logins?
• What happens when a payer sends a PLB adjustment affecting three clients in one 835?

Where CollaborateMD is stronger

Track record is real. CollaborateMD has done this since 1999, and the product has billing-service-shaped edges that only come from years in the use case — useful when you are betting on a vendor surviving payer-portal changes, clearinghouse outages, and CMS rule updates.

EHR integration breadth is genuine. Twenty-plus HL7 connections, preferred partners free and lab interfaces as paid add-ons, means a diverse client base can usually find a connection path without a custom integration project.

The 99% first-pass acceptance claim is marketing, but it points to real scrubbing investment: CCI, NCD/LCD, LMRP, and modifier validations are Level 2 edits that stop rules-based denials before submission. A billing company inheriting clients from a looser system may find that depth catches rejections it was absorbing.

Enrollment at scale is proven. CollaborateMD has managed payer enrollment and clearinghouse relationships for years, and the phased implementation with a dedicated enrollments specialist is a documented offering.

Where Medi is stronger

Pricing transparency is a meaningful difference. Medi publishes its platform fee and EDI rates at /pricing; CollaborateMD does not publish pricing on its own site. A BestNotes partner price sheet lists estimated per-claim and per-provider figures, but billing-company subscription tiers are gated behind a quote. You cannot model your per-practice subscription cost at 30, 60, or 100 practices without entering a sales process.

The ERA and denial review layer is built for operator decisions: the BPR check footer, CARC and RARC codes translated to plain English, per-line decisions (accept, reject, route to follow-up, escalate), PLB segments as distinct entries, and posting presets for common payer patterns. CollaborateMD offers ERA auto-posting and remittance handling, but its model is automated-by-default rather than decision-surfacing-by-design.

Document storage is not capped. Capterra reviewers flag CollaborateMD's per-megabyte charges directly: "Still charge per MB to store documents like we are back in the early 2000's." For a book that attaches EOBs, appeal letters, authorization records, and clinical documentation to claims, the storage model is a recurring cost.

Audit log retention is seven years by default, aligned with HIPAA §164.312(b). Verify CollaborateMD's windows against your state and payer-contract requirements before assuming they match. Medi's BAA is also signed before any PHI touches the system, which matters for a billing company's own HIPAA obligations as a business associate.

Migration considerations

CollaborateMD's built-in clearinghouse is eProviderSolutions (ePS), an EverHealth sibling, not a neutral third party. Leaving CollaborateMD means leaving ePS: every payer needs fresh transaction enrollment through Stedi, the clearinghouse Medi routes on, and that runs two to six weeks per payer. CollaborateMD exports patient demographics, claim history, and payment records on formal request, but its Customer Software Agreement permits account deletion after termination, so the export must be requested before the account closes.

Working state does not export from any system. In-flight appeals, open-claim follow-up notes, and unposted ERAs are not in any data file. The pattern that protects revenue works in either direction:

• **Legacy A/R closeout:** leave the last 60 to 90 days of claims in the outgoing system for collection; migrate forward-only.
• **Parallel ERA posting:** run both systems two to three weeks so remittance totals reconcile before cutover.
• **Enrollment first:** payer IDs and trading-partner relationships are planned and tested before cutover — a missed enrollment bounces a clean claim on day one.
• **Practice-by-practice rollout:** move the simplest client first, validate, then move the rest.

The full sequence — the ePS-to-Stedi switch, the day-zero checklist, and what does not migrate — is in the CollaborateMD migration guide.

What should a billing company verify before choosing?

Test both platforms on the work that happens every week, not on the feature checklist.

For CollaborateMD: confirm the per-provider fee at your current provider count and project it two and four years out. Confirm whether your quoted tier includes unlimited ERA and eligibility or caps them. Confirm document storage limits and overage costs. Confirm the clearinghouse is ePS and whether that conflicts with any payer relationship or enrollment contract you already hold. Verify support hours and escalation paths — reviewers note phone support is not available during clearinghouse outages, and chat support ends at 6 PM ET.

For Medi: confirm Stedi supports every payer your clients bill. Confirm BAA timing relative to when PHI enters the system. Confirm implementation review requirements and timing before production access. Confirm EDI usage cost at your current claim and ERA volume before committing to a budget.

For both: run the multi-practice navigation test with a real scenario. Assign a poster to three client practices, verify they cannot see the fourth, then follow one cross-client denial from queue to appeal submission without leaving the denial-lead view. That experience predicts daily satisfaction better than any comparison table.

Is Medi always a better fit than CollaborateMD?

No. CollaborateMD has a longer track record, a larger reference base, and more established payer-enrollment infrastructure than Medi at this point. If those are your decision criteria — and for some billing companies they reasonably are — CollaborateMD may be the right answer. It is also stronger when your clients are on a dozen different EHRs and expect clean data flow without integration projects; twenty-plus HL7 connections give it an edge a billing-only platform does not carry.

There is also a pricing-model preference unrelated to product quality. Some owners prefer per-provider pricing because it maps directly to how they bill clients. Medi's per-practice model means adding providers inside a client never raises the software cost, but it also does not drop if a client cuts providers mid-year. If your client contracts are built around per-provider rates, Medi's shape may need a different internal accounting model.

Medi is for billing companies that want a billing-company-first architecture, per-practice pricing that steps down as the book grows, and workflow depth at the denial and ERA review layer. CollaborateMD is for those that want established infrastructure, EHR integration breadth, and a vendor serving the use case since before ICD-10. Both are legitimate, depending on what your organization needs.

Other comparisons billing companies look at

CollaborateMD competes most directly with Tebra and AdvancedMD for the multi-practice billing-company buyer. PracticeSuite shows up on the same shortlist for clinical-plus-billing buyers.

• Medi vs Tebra: the largest EHR-plus-billing player, on per-provider pricing.
• Medi vs AdvancedMD — per-provider PM with explicit Central Billing Office packaging.
• Medi vs PracticeSuite: multi-tenant billing-service product with deeper EHR bundling.
• Medi vs Claim.MD — clearinghouse-focused with basic billing; lower cost than CollaborateMD.
• Medi vs Office Ally — free-tier clearinghouse with Practice Mate PM.
• Medi vs Availity: payer-network and clearinghouse layer that complements rather than replaces CollaborateMD.
• Medi vs Waystar — enterprise RCM, usually too heavy for a CollaborateMD-scale book.
• Best CollaborateMD alternatives for billing companies — the full field of options beyond the head-to-head pages.

The billing-company software evaluation guide covers the criteria that separate billing-company-first platforms from practice management with billing bolted on.

Frequently asked questions

How does CollaborateMD's pricing work for a billing company?

CollaborateMD does not publish pricing on its own site. A BestNotes partner price sheet lists about $0.38 per claim (declining to about $0.19 at high volume) and about $54 per provider, with a $235/month account-level minimum also cited in partner materials. Billing-company subscription tiers are gated and come by private quote. Reviewer data also describes per-provider banding by monthly claim volume: providers at 75+ claims pay the full provider rate, 6 to 74 claims pay half, and 1 to 5 claims pay a minor rate (~$29 to $34 per provider per reviewer data). Additional tax ID add-ons run ~$125 each per reviewer reports. Exact current subscription rates require a direct quote.

Does CollaborateMD own its clearinghouse or use a third party?

CollaborateMD's built-in clearinghouse is eProviderSolutions (ePS), an EverHealth sibling company, not a neutral third party. Before migrating, confirm that against any payer relationship, enrollment contract, or trading-partner agreement you already hold with a clearinghouse like Availity, Waystar, or Change Healthcare, since leaving CollaborateMD means leaving ePS. Medi routes through Stedi, which is publicly documented.

What do billing companies say about CollaborateMD in reviews?

Capterra and G2 reviewers consistently praise reporting flexibility — "I really like being able to create our own reports" and customizing reports "to our clients' specific needs" are representative. Common criticisms: per-megabyte document storage charges, ERA posting outages with limited phone support during them, and difficulty modifying finalized claims. Support availability is flagged for teams outside Eastern hours, where chat support ends at 6 PM ET.

Can a billing company migrate from CollaborateMD to Medi?

Yes, though it is not trivial. The standard pattern is forward-only: leave 60 to 90 days of legacy claims in CollaborateMD for collection, migrate active practices into Medi one at a time, and run parallel ERA posting two to three weeks to reconcile totals. Enrollment — payer IDs, trading-partner relationships, ERA receiver connections — happens before cutover, not after. Historical records can stay in CollaborateMD on read-only access for the two-year minimum most books need for audit. Medi migration is free with a 12-month commitment, or $100 per practice (capped at $3,000) month to month; data export is always free, with no early-termination fee. Full sequence: the CollaborateMD migration guide.

Is CollaborateMD part of a larger company, and does that matter?

EverCommerce acquired CollaborateMD in 2019, and it now sits in the EverHealth division alongside Updox, AlertMD, and MDTech. EverCommerce is public (NASDAQ: EVCM) and operates across several service verticals. For some billing companies, that means more stable infrastructure and longer vendor continuity. For others, it raises questions about roadmap independence and whether billing-company features stay a priority inside a larger portfolio. Worth asking directly in a sales conversation.

What should a billing company ask in a CollaborateMD demo?

Walk a specific scenario, not a feature tour. Ask the sales team to show: adding a new client practice and restricting one poster to that client only; working three clients' open denials from a single queue; finding a PLB segment in a recent ERA and tracing it to the claim it offset; drilling into days-in-A/R for one client from the all-book view; and exporting a denial trend report by payer across all clients for the last 90 days. Those five cover the work that separates platforms in daily operation. The same five work for a Medi walkthrough.

How current is this comparison?

Last reviewed 2026-06-07. CollaborateMD's pricing, packaging, and feature scope change, and EverHealth's roadmap evolves inside EverCommerce. Source for current positioning: collaboratemd.com/medical-billing-companies; per-claim and per-provider figures reflect the BestNotes partner price sheet and Capterra/G2 reviewer data at the time of review; CollaborateMD does not publish pricing on its own site. Verify current quotes directly with CollaborateMD before any migration decision.